Radiation Oncology (London, England) | 2021

Dosimetric benefits of daily treatment plan adaptation for prostate cancer stereotactic body radiotherapy

 
 
 
 
 
 
 
 
 

Abstract


Background Hypofractionation is increasingly being applied in radiotherapy for prostate cancer, requiring higher accuracy of daily treatment deliveries than in conventional image-guided radiotherapy (IGRT). Different adaptive radiotherapy (ART) strategies were evaluated with regard to dosimetric benefits. Methods Treatments plans for 32 patients were retrospectively generated and analyzed according to the PACE-C trial treatment scheme (40\xa0Gy in 5 fractions). Using a previously trained cycle-generative adversarial network algorithm, synthetic CT (sCT) were generated out of five daily cone-beam CT. Dose calculation on sCT was performed for four different adaptation approaches: IGRT without adaptation, adaptation via segment aperture morphing (SAM) and segment weight optimization (ART1) or additional shape optimization (ART2) as well as a full re-optimization (ART3). Dose distributions were evaluated regarding dose-volume parameters and a penalty score. Results Compared to the IGRT approach, the ART1, ART2 and ART3 approaches substantially reduced the V 37Gy (bladder) and V 36Gy (rectum) from a mean of 7.4cm 3 and 2.0cm 3 to (5.9cm 3 , 6.1cm 3 , 5.2cm 3 ) as well as to (1.4cm 3 , 1.4cm 3 , 1.0cm 3 ), respectively. Plan adaptation required on average 2.6\xa0min for the ART1 approach and yielded doses to the rectum being insignificantly different from the ART2 approach. Based on an accumulation over the total patient collective, a penalty score revealed dosimetric violations reduced by 79.2%, 75.7% and 93.2% through adaptation. Conclusion Treatment plan adaptation was demonstrated to adequately restore relevant dose criteria on a daily basis. While for SAM adaptation approaches dosimetric benefits were realized through ensuring sufficient target coverage, a full re-optimization mainly improved OAR sparing which helps to guide the decision of when to apply which adaptation strategy.

Volume 16
Pages None
DOI 10.1186/s13014-021-01872-9
Language English
Journal Radiation Oncology (London, England)

Full Text